Literature DB >> 17334409

CD95 ligand-dependant endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease.

Christophe Deschaumes1, Laurence Verneuil, Marjan Ertault-Daneshpouy, Homa Adle-Biassette, Françoise Galateau, Fadela Aïnoun, Juliette Micic-Polianski, Anne Janin, Jean C Ameisen.   

Abstract

Oral mucosa lesions are one of the common pathological consequences of acute graft versus host disease (aGVHD), the major complication of allogeneic bone marrow transplantation caused by mature T lymphocytes of donor origin. Oral mucosa damage in aGVHD is characterized by apoptosis induction in the basal keratinocytes, associated with immune effector T-cell infiltration, but its pathogenesis remains unclear because these lesions might result from the patient conditioning therapy that includes radiation and/or chemotherapy. Here, using a murine model of aGVHD that does not involve any conditioning treatment, we show that the earliest detectable oral mucosa lesion is apoptosis of the endothelial cells from chorion capillaries, which precedes basal keratinocyte apoptosis induction. Neither vascular damage nor epithelial-cell death occurred in recipients of allogeneic lymphocytes from CD95 ligand (CD95L)-defective mice. Our findings indicate that oral mucosa lesions in aGVHD are initiated by endothelial-cell death and require CD95L expression by the allogeneic lymphocytes. This early vascular damage may contribute to the induction of further tissue damage in the oral mucosa, through the induction of hypoxia and vascular leakage of immune cells or soluble proapoptotic mediators.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334409     DOI: 10.1038/labinvest.3700541

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

1.  Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease.

Authors:  Jianfeng Yao; Axia Song; Wenbin Cao; Shulian Chen; Lukun Zhou; Shannan Cao; Peng Liu; Mei Wang; Yuanfu Xu; Aiming Pang; Sizhou Feng; Mingzhe Han
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

Review 2.  Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.

Authors:  Shernan G Holtan; Mukta Arora
Journal:  Transl Res       Date:  2015-06-09       Impact factor: 7.012

3.  Peripheral tolerance can be modified by altering KLF2-regulated Treg migration.

Authors:  Sudheer K Pabbisetty; Whitney Rabacal; Emmanuel J Volanakis; Vrajesh V Parekh; Danyvid Olivares-Villagómez; Delphine Cendron; Kelli L Boyd; Luc Van Kaer; Eric Sebzda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-26       Impact factor: 11.205

4.  Proteinase-activated receptor-1 mediates allogeneic CD8(+) T cell-induced apoptosis of vascular endothelial cells.

Authors:  Li Quan; Zhang Jian; Zou Ping; Li Weiming
Journal:  Med Oncol       Date:  2008-12-10       Impact factor: 3.064

Review 5.  The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

Authors:  Kenneth R Cooke; Leo Luznik; Stefanie Sarantopoulos; Frances T Hakim; Madan Jagasia; Daniel H Fowler; Marcel R M van den Brink; John A Hansen; Robertson Parkman; David B Miklos; Paul J Martin; Sophie Paczesny; Georgia Vogelsang; Steven Pavletic; Jerome Ritz; Kirk R Schultz; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

6.  [Vascular endothelial injury induced by anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation].

Authors:  Jianfeng Yao; Axia Song; Zheng Ruan; Lukun Zhou; Peng Liu; Haiyan Zhu; Haiyan Gong; Shuxu Dong; Yuanfu Xu; Erlie Jiang; Aiming Pang; Sizhou Feng; Mingzhe Han
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2015-06

Review 7.  Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation.

Authors:  Wei Du; Xuefang Cao
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

8.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Authors:  Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny
Journal:  Transplant Cell Ther       Date:  2021-06-10

9.  In vitro inhibition of HUVECs by low dose methotrexate - insights into oral adverse events.

Authors:  Tobias Annussek; Thomas Szuwart; Johannes Kleinheinz; Cathrin Koiky; Kai Wermker
Journal:  Head Face Med       Date:  2014-05-22       Impact factor: 2.151

10.  Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease.

Authors:  David García-Bernal; Marta Palomo; Carlos M Martínez; José E Millán-Rivero; Ana I García-Guillén; Miguel Blanquer; Maribel Díaz-Ricart; Robert Sackstein; Enric Carreras; Jose M Moraleda
Journal:  J Cell Mol Med       Date:  2020-06-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.